# IDVYNSO

NDC: 0006-5092
Generic name: Doravirine, Islatravir
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260423

FDA application: NDA216964

## Active ingredients

- DORAVIRINE: 100 mg/1
- ISLATRAVIR ANHYDROUS: .25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-5092"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5092
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11aaeb53-9848-433c-be7f-db8a5bc0b26f